国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2012年
7期
953-955
,共3页
顽固高眼压性青光眼%手术%疗效%并发症
頑固高眼壓性青光眼%手術%療效%併髮癥
완고고안압성청광안%수술%료효%병발증
Ocular hypertensionglaucoma%Surgery%Efficacy%Complications
目的 对比研究手术治疗顽固性高眼压性青光眼的治疗效果,为临床治疗提供指导.方法 选择2007年1月-2011年12月于我院进行顽固性高眼压性青光眼治疗的患者84例为研究对象；进行手术治疗,观察患者治疗前后眼压和并发症情况.结果 治疗后患者眼压显著下降,2例由治疗前的＞ 50 mmHg下降为40～49 mmHg,16例由40 - 49 mmHg降至21～40 mmHg,其余全降为正常,治疗前、后眼压差异具有显著性(P＜0.05)；治疗后,22.55％的患者视力＜0.02,62.75％的患者视力0.02 ～ 0.3,14.70％的患者视力＞0.3；治疗后患者视力明显好转(尸＜ 0.05),且未出现严重并发症.结论 手术方法治疗顽固性高眼压性青光眼有效,且并发症发生率低,值得临床广泛推广.
目的 對比研究手術治療頑固性高眼壓性青光眼的治療效果,為臨床治療提供指導.方法 選擇2007年1月-2011年12月于我院進行頑固性高眼壓性青光眼治療的患者84例為研究對象；進行手術治療,觀察患者治療前後眼壓和併髮癥情況.結果 治療後患者眼壓顯著下降,2例由治療前的＞ 50 mmHg下降為40～49 mmHg,16例由40 - 49 mmHg降至21～40 mmHg,其餘全降為正常,治療前、後眼壓差異具有顯著性(P＜0.05)；治療後,22.55％的患者視力＜0.02,62.75％的患者視力0.02 ～ 0.3,14.70％的患者視力＞0.3；治療後患者視力明顯好轉(尸＜ 0.05),且未齣現嚴重併髮癥.結論 手術方法治療頑固性高眼壓性青光眼有效,且併髮癥髮生率低,值得臨床廣汎推廣.
목적 대비연구수술치료완고성고안압성청광안적치료효과,위림상치료제공지도.방법 선택2007년1월-2011년12월우아원진행완고성고안압성청광안치료적환자84례위연구대상；진행수술치료,관찰환자치료전후안압화병발증정황.결과 치료후환자안압현저하강,2례유치료전적＞ 50 mmHg하강위40～49 mmHg,16례유40 - 49 mmHg강지21～40 mmHg,기여전강위정상,치료전、후안압차이구유현저성(P＜0.05)；치료후,22.55％적환자시력＜0.02,62.75％적환자시력0.02 ～ 0.3,14.70％적환자시력＞0.3；치료후환자시력명현호전(시＜ 0.05),차미출현엄중병발증.결론 수술방법치료완고성고안압성청광안유효,차병발증발생솔저,치득림상엄범추엄.
Objective To provide instruction for clinical treatment by investigating the efficacy of surgical treatment for refractory ocular hypertension glaucoma.Methods g4 patients who bad undergone surgery for refractory ocular hypertension glaucoma during the period of January 2007 to December 2011 in our hospital were included in this study.Intraocular pressure and incidence of complications were observed before and after treatment.Results Intraocular pressure decreased significantly in all the patients after the treatment,with a significant statistical difference ( P＜ 0.05 ).After treatment,22.55％of the patients had visual acuity of ＜ 0.03,62.75％ had 0.02 to 0.3,and 14.70％ had ＞ 0.3,revealing significant improvement ( P ＜ 0.05 ).No severe complications occurred.Conclusions Surgical treatment for refractory ocular hypertension glaucoma is efficacious and has a lower rate of complications.It is worth popularizing clinically.
